IL120477A0 - Fluoroalkyl - and fluoroalkoxy-substituted heterocyclic bradykinin antagonists process for their preparation and their use - Google Patents
Fluoroalkyl - and fluoroalkoxy-substituted heterocyclic bradykinin antagonists process for their preparation and their useInfo
- Publication number
- IL120477A0 IL120477A0 IL12047797A IL12047797A IL120477A0 IL 120477 A0 IL120477 A0 IL 120477A0 IL 12047797 A IL12047797 A IL 12047797A IL 12047797 A IL12047797 A IL 12047797A IL 120477 A0 IL120477 A0 IL 120477A0
- Authority
- IL
- Israel
- Prior art keywords
- fluoroalkoxy
- fluoroalkyl
- preparation
- substituted heterocyclic
- bradykinin antagonists
- Prior art date
Links
- 239000003152 bradykinin antagonist Substances 0.000 title 1
- 125000003709 fluoroalkyl group Chemical group 0.000 title 1
- 125000000623 heterocyclic group Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/10—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D257/12—Six-membered rings having four nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19610784A DE19610784A1 (de) | 1996-03-19 | 1996-03-19 | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL120477A0 true IL120477A0 (en) | 1997-07-13 |
Family
ID=7788755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12047797A IL120477A0 (en) | 1996-03-19 | 1997-03-18 | Fluoroalkyl - and fluoroalkoxy-substituted heterocyclic bradykinin antagonists process for their preparation and their use |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5859025A (cs) |
| EP (1) | EP0796848B1 (cs) |
| JP (1) | JP4199315B2 (cs) |
| KR (1) | KR970065522A (cs) |
| AR (1) | AR006261A1 (cs) |
| AT (1) | ATE242215T1 (cs) |
| AU (1) | AU1628397A (cs) |
| BR (1) | BR9701332A (cs) |
| CA (1) | CA2199925A1 (cs) |
| CZ (1) | CZ81097A3 (cs) |
| DE (2) | DE19610784A1 (cs) |
| DK (1) | DK0796848T3 (cs) |
| ES (1) | ES2196207T3 (cs) |
| HR (1) | HRP970155A2 (cs) |
| HU (1) | HUP9700595A1 (cs) |
| ID (1) | ID16274A (cs) |
| IL (1) | IL120477A0 (cs) |
| NO (1) | NO971238L (cs) |
| PL (1) | PL318924A1 (cs) |
| PT (1) | PT796848E (cs) |
| SI (1) | SI0796848T1 (cs) |
| SK (1) | SK34897A3 (cs) |
| TR (1) | TR199700206A2 (cs) |
| ZA (1) | ZA972328B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19712960A1 (de) * | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
| EP1106614B1 (en) * | 1999-12-10 | 2004-01-07 | Pfizer Inc. | 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| WO2003087090A2 (en) * | 2002-04-10 | 2003-10-23 | Ortho-Mcneil Pharmaceutical,Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| EP1914236A1 (en) | 2002-04-10 | 2008-04-23 | Ortho-McNeil Pharmaceutical, Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| ITMI20021247A1 (it) * | 2002-06-07 | 2003-12-09 | Menarini Ricerche Spa | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
| US7256207B2 (en) | 2003-08-20 | 2007-08-14 | Irm Llc | Inhibitors of cathepsin S |
| BRPI0607404A2 (pt) | 2005-03-01 | 2009-09-01 | Wyeth Corp | compostos de cinolina e seu uso como moduladores de receptor de x hepático |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| AR085073A1 (es) * | 2012-01-11 | 2013-09-11 | Richmond Sa Com Ind Y Financiera Lab | Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden |
| WO2019101906A1 (en) | 2017-11-24 | 2019-05-31 | Pharvaris B.V. | Novel bradykinin b2 receptor antagonists |
| UY38706A (es) | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| UY38707A (es) | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Nuevos antagonistas cíclicos del receptor b2 de bradiquinina |
| RS65427B1 (sr) | 2021-08-05 | 2024-05-31 | Pharvaris Gmbh | Kompozicija na bazi lipida za oralnu primenu antagonista receptora bradikinina b2 |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
| EP4499100A1 (en) | 2022-03-25 | 2025-02-05 | Pharvaris GmbH | Therapeutic uses of bradykinin b2-receptor antagonists |
| IL315699A (en) | 2022-03-25 | 2024-11-01 | Pharvaris Gmbh | A solid composition comprising dissolved bradykinin B2 receptor antagonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5212182A (en) * | 1990-10-03 | 1993-05-18 | American Home Products Corpooration | Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics |
| US5216165A (en) * | 1990-10-03 | 1993-06-01 | American Home Products Corporation | N-substituted aminoquinolines as analgesic agents |
| US5438064A (en) * | 1991-12-23 | 1995-08-01 | American Home Products Corporation | Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents |
| AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| WO1996005202A1 (en) * | 1994-08-17 | 1996-02-22 | Nippon Hypox Laboratories Inc. | Imidazoquinoline derivative |
| EP0807105B1 (en) * | 1994-10-27 | 2004-06-16 | Fujisawa Pharmaceutical Co., Ltd. | Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
-
1996
- 1996-03-19 DE DE19610784A patent/DE19610784A1/de not_active Withdrawn
-
1997
- 1997-03-05 ES ES97103611T patent/ES2196207T3/es not_active Expired - Lifetime
- 1997-03-05 AT AT97103611T patent/ATE242215T1/de not_active IP Right Cessation
- 1997-03-05 DK DK97103611T patent/DK0796848T3/da active
- 1997-03-05 SI SI9730572T patent/SI0796848T1/xx unknown
- 1997-03-05 DE DE59710191T patent/DE59710191D1/de not_active Expired - Lifetime
- 1997-03-05 PT PT97103611T patent/PT796848E/pt unknown
- 1997-03-05 EP EP97103611A patent/EP0796848B1/de not_active Expired - Lifetime
- 1997-03-12 PL PL97318924A patent/PL318924A1/xx unknown
- 1997-03-13 CA CA002199925A patent/CA2199925A1/en not_active Abandoned
- 1997-03-17 SK SK348-97A patent/SK34897A3/sk unknown
- 1997-03-17 KR KR1019970008899A patent/KR970065522A/ko not_active Withdrawn
- 1997-03-17 HU HU9700595A patent/HUP9700595A1/hu unknown
- 1997-03-17 ID IDP970863A patent/ID16274A/id unknown
- 1997-03-17 AU AU16283/97A patent/AU1628397A/en not_active Abandoned
- 1997-03-17 AR ARP970101058A patent/AR006261A1/es unknown
- 1997-03-17 TR TR97/00206A patent/TR199700206A2/xx unknown
- 1997-03-17 CZ CZ97810A patent/CZ81097A3/cs unknown
- 1997-03-18 NO NO971238A patent/NO971238L/no unknown
- 1997-03-18 HR HR19610784.9A patent/HRP970155A2/xx not_active Application Discontinuation
- 1997-03-18 JP JP06474897A patent/JP4199315B2/ja not_active Expired - Lifetime
- 1997-03-18 BR BR9701332A patent/BR9701332A/pt not_active Application Discontinuation
- 1997-03-18 IL IL12047797A patent/IL120477A0/xx unknown
- 1997-03-18 US US08/819,351 patent/US5859025A/en not_active Expired - Lifetime
- 1997-03-18 ZA ZA9702328A patent/ZA972328B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ID16274A (id) | 1997-09-18 |
| PT796848E (pt) | 2003-08-29 |
| TR199700206A2 (xx) | 1997-10-21 |
| DE59710191D1 (de) | 2003-07-10 |
| DK0796848T3 (da) | 2003-09-22 |
| PL318924A1 (en) | 1997-09-29 |
| EP0796848B1 (de) | 2003-06-04 |
| ZA972328B (en) | 1997-09-19 |
| AR006261A1 (es) | 1999-08-11 |
| NO971238D0 (no) | 1997-03-18 |
| CA2199925A1 (en) | 1997-09-19 |
| JPH107656A (ja) | 1998-01-13 |
| BR9701332A (pt) | 1998-08-18 |
| AU1628397A (en) | 1997-09-25 |
| KR970065522A (ko) | 1997-10-13 |
| HU9700595D0 (en) | 1997-05-28 |
| CZ81097A3 (en) | 1997-10-15 |
| JP4199315B2 (ja) | 2008-12-17 |
| SI0796848T1 (en) | 2003-12-31 |
| HRP970155A2 (en) | 1998-04-30 |
| MX9702028A (es) | 1997-09-30 |
| ATE242215T1 (de) | 2003-06-15 |
| NO971238L (no) | 1997-09-22 |
| EP0796848A1 (de) | 1997-09-24 |
| DE19610784A1 (de) | 1997-09-25 |
| SK34897A3 (en) | 1998-01-14 |
| HUP9700595A1 (hu) | 2000-08-28 |
| US5859025A (en) | 1999-01-12 |
| ES2196207T3 (es) | 2003-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9503045D0 (en) | Heterocyclic compounds and their preparation and use | |
| AP9901444A0 (en) | Erythrommycins and process for their preparation | |
| IL125076A0 (en) | Substituted aza- and diazacycloheptane and- cyclooctane compounds and their use | |
| PL332629A1 (en) | Heterocyclic aralakyl and aralkylydene lactams and imides | |
| HRP970333A2 (en) | Heterocyclic condensed pyridines | |
| PL331795A1 (en) | Heterocyclic metaloprotease inhibitors | |
| IL130660A0 (en) | Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them | |
| EP0788489A4 (en) | HETEROCYCLIC COMPOUNDS AND THEIR USE | |
| IL136308A0 (en) | Antipicornaviral compounds and methods for their use and preparation | |
| IL120477A0 (en) | Fluoroalkyl - and fluoroalkoxy-substituted heterocyclic bradykinin antagonists process for their preparation and their use | |
| IL116525A0 (en) | Piperazinedione derivatives their preparation and use | |
| HU9503191D0 (en) | Adhesion-receptor antagonists | |
| HRP970138A2 (en) | Aminoalkyl- and acylaminoalkyl esters, process for their preparation and their use as bradykinin receptor antagonists | |
| IL128631A0 (en) | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists | |
| GB9705035D0 (en) | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation | |
| IL114490A0 (en) | Heterocyclic compounds their preparation and their use | |
| AU3116697A (en) | Human interleukin-1j and antagonists thereof | |
| IL119703A0 (en) | LH-RH antagonists and processes for their preparation | |
| GB9702807D0 (en) | Alkynyl-substituted camptothecins and process for their preparation | |
| GB9417969D0 (en) | Alkaloids and derivatives thereof | |
| GB9623283D0 (en) | Heterocyclic derivatives | |
| HUP9903870A3 (en) | Piperazine derivatives and process for the preparation thereof | |
| ZA976378B (en) | Heterocyclic compounds their production and use | |
| ZA972790B (en) | Heterocyclic compounds and their preparation and use. | |
| AU1794397A (en) | Use of alpha1-adrenoceptor antagonists |